posted on 2003-12-26, 00:00authored byYoung-Ah Kim, Hae-Mi Chung, Jin-Seon Park, Wonja Choi, Juyoung Min, Nok-Hyun Park, Ki-Hwan Kim, Gil-Ja Jhon, So-Yeop Han
Four novel lysophosphatidylcholine (lysoPC)
analogues, (S)-N-stearoyl-O-phosphocholineserine methyl
ester [(S)-1a], (R)-1-lyso-2-stearoylamino-2-deoxy-sn-glycero-3-phosphatidylcholine [(R)-2a], (R)-N-stearoyl-O-phosphocholineserine methyl ester [(R)-1b], and (S)-1-lyso-2-stearoylamino-2-deoxy-sn-glycero-3-phosphatidylcholine [(S)-2b], were
synthesized starting from serine as a chiral template. These
synthetic compounds exhibited greatly enhanced hyphal
transition inhibitory activity in Candida as compared to the
natural lysoPC.